Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202610491064730Not yet recruiting
Trial of sufentanil in pain (2 arms), sponsored by Sahloul Hospital. Primary endpoints: Incidence of clinically significant tourniquet pain and Pain intensity on Visual Analog Scale. Planned start Nov 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202610491064730.